Effect of a Hospital-Initiated Program Combining Transitional Care and Long-term Self-management Support on Outcomes of Patients Hospitalized With Chronic Obstructive Pulmonary DiseaseA Randomized Clinical Trial

Corresponding Author: Hanan Aboumatar, MD, MPH, Armstrong Institute for Patient Safety and Quality, Johns Hopkins School of Medicine, 750 E Pratt St, 15th Floor, Baltimore, MD 21202 (habouma1@jhmi.edu).

Accepted for Publication: July 23, 2019.

Author Contributions: Dr Aboumatar had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Concept and design: Aboumatar, Naqibuddin, Chung, Chaudhry, Bone, Gurses, Knowlton, Pronovost, Rand, Roter, Sylvester, Wolff, Hibbard, Wise.

Acquisition, analysis, or interpretation of data: Aboumatar, Naqibuddin, Chung, Kim, Saunders, Pronovost, Putcha, Rand, Thompson, Wise.

Drafting of the manuscript: Aboumatar, Naqibuddin, Chung, Chaudhry, Thompson, Hibbard, Wise.

Critical revision of the manuscript for important intellectual content: Aboumatar, Naqibuddin, Chung, Chaudhry, Kim, Saunders, Bone, Gurses, Knowlton, Pronovost, Putcha, Rand, Roter, Sylvester, Thompson, Wolff, Wise.

Statistical analysis: Aboumatar, Chung, Thompson.

Obtained funding: Aboumatar, Gurses, Rand.

Administrative, technical, or material support: Aboumatar, Naqibuddin, Chung, Chaudhry, Kim, Saunders, Bone, Gurses, Roter, Sylvester, Wise.

Supervision: Aboumatar, Naqibuddin, Pronovost, Hibbard.

Conflict of Interest Disclosures: Drs Aboumatar, Saunders, Gurses, and Wolff; Ms Chung; Ms Chaudhry; and Mr Kim reported receiving grants from the Patient-Centered Outcomes Research Institute (PCORI). Dr Putcha reported receiving grants from the National Heart, Lung, and Blood Institute. Dr Hibbard reported receiving personal fees from Insignia Health and having equity ownership in Insignia Health, as well as receiving royalties on the Patient Activation Measure paid by Insignia Health through the University of Oregon. Dr Wise reported receiving grants and personal fees from AstraZeneca/Medimmune, Boehringer Ingelheim, and GlaxoSmithKline; personal fees from AbbVie, Contrafect, Kiniksa, Novartis, Pulmonx, Roche, Spiration, Sunovion, Syneos, Merck, Circassia, Pneuma, Verona, Bonti, Denali, and Aradigm; grants from Pearl Therapeutics and Sanofi; and nonfinancial support from Propeller Health. No other disclosures were reported.

Funding/Support: Funding was provided by PCORI (Award IHS 1304-7118).

Role of the Funder/Sponsor: PCORI had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Disclaimer: The opinions in this publication are solely the responsibility of the authors and do not necessarily represent the views of PCORI, its board of governors, or methodology committee.

Meeting Presentation: This study was presented at the American Public Health 2018 Annual Meeting; November 12, 2018; San Diego, California.

Data Sharing Statement: See Supplement 4.

Additional Contributions: We acknowledge the important contributions of Edna Shattuck, RN, RRT, a study co-investigator and patient partner who died before publication of study results, and all the members of the BREATHE Patient Family Partners Group. They were compensated for their role in the study. We are also grateful for the support from the Johns Hopkins Homecare Group (Hajara Adebowale, RN, BSN; Donna Kurtz, RN; Leslie Piet, RN, MA, CCM, CHPN; Laura Syron, RN, MSN, MPH; and Mary Myers, MS, RN) and the Johns Hopkins Biostatistics Center. Ms Adebowale, Ms Kurtz, and Ms Piet performed the role of the chronic obstructive pulmonary disease nurse on study and were paid for this work. Ms Syron and Ms Myers were not compensated. The Johns Hopkins Biostatistics Center received compensation. We thank the members of the BREATHE Study data safety and monitoring board: David Levine, MD (Johns Hopkins University); Albert Wu, MD (Johns Hopkins University); Sanjay V. Desai, MD (Johns Hopkins University); and John Linnell (patient advocate on the board). Drs Levine, Wu, and Desai received no compensation for their role in the study; Mr Linnell received an honorarium. We also acknowledge the support and contributions of Kai Shea, MSW, LCSW-C (Johns Hopkins Bayview Social Work Department); Jamie Sullivan, MPH (COPD Foundation); Eric E. Howell, MD (Johns Hopkins Hospitalist service); Emmanuel Garcia-Morales, PhD (Johns Hopkins Armstrong Institute); and Joseph Neiman, MD (Johns Hopkins Armstrong Institute). Ms Shea was not compensated. Ms Sullivan and Drs Howell, Garcia-Morales, and Neiman were compensated for their role in the study.

Additional Information: This article is a corrected version of an article that has been retracted (Aboumatar H, Naqibuddin M, Chung S, et al. Effect of a program combining transitional care and long-term self-management support on outcomes of hospitalized patients with chronic obstructive pulmonary disease: a randomized clinical trial. JAMA. 2018;320(22):2335-2343 doi:10.1001/jama.2018.17933).